Advanced medical training
By researcher Giovanni Puccio.
The seminar will be held at the end of January and will be available only to Contributing Members. Register now.
What it is
CRAPU (Puccio's Complementary Anti-degenerative Reducing Therapy) is a biochemical approach that does not cure any disease.
Its purpose is to restore cellular redox balance, which is compromised by chronic oxidative stress.
In practice:
By doing so:
CRAPU does not replace medical therapies: it makes them biochemically possible.
Listen
The course
This intensive seminar gives doctors a unique opportunity to learn, directly from the founder of the C.R.A.Pu. methodology (Complementary Reducing Anti-degenerative Puccio), the biochemical principles needed to tackle degenerative and viral diseases and the damage caused by acquired immunodeficiency.
The course is aimed at doctors of “good sense” who use “Science and Conscience” every day and want to go beyond symptomatic treatment and act on the primary biochemical causes of disease.
The seminar teaches how to restore the patient's “molecular shield”, allowing the immune system to recover its natural healing capacity — a capacity often compromised by standard protocols that take no account of the cellular electrochemical balance.
Hands-on learning of infusion therapy: dosages, sequences and synergies.
Which tests to prescribe in order to see what standard protocols ignore. Critical reading of:
You will learn to read the patient's “biological terrain” and to apply a therapy described as “uneconomic” yet extraordinarily effective, capable of results where conventional medicine often stops at palliation or at turning the disease into a chronic one.
The seminar provides the tools to work in “science and conscience”, giving doctors back the role of true healer by restoring the fundamental laws of biology.
Who runs the seminar
Learning the “CraPu” procedure to save lives.
Giovanni Puccio is an expert in basic structural chemistry, a field in which he has worked since 1977, and an independent researcher from Palermo focused on the etiopathogenesis of degenerative diseases. His oncology research began in 1992, driven by the desire to understand the biochemical mechanisms behind the formation of infiltrating tumors and their ability to evade the immune system.
Below are the key points that define his profile and work:
Reported cases
A Sicilian patient, diagnosed in 2004 with end-stage squamous cell lung carcinoma and sent home to die, was later declared completely cured by physicians after being successfully treated using the biochemical approach developed by researcher Puccio.
A documented case involved a patient with glioblastoma, an extremely aggressive brain tumor, who achieved a 57% reduction in tumor mass in just four months of treatment.
A general practitioner reported having successfully treated about 1,200 patients infected with SARS-CoV-2 by integrating the principles of CRAPU therapy into a home-care protocol, with only three total hospitalizations recorded.
Several doctors working in the field have documented significant clinical improvement in patients with paralysis, paraesthesia and neurological problems attributed to the persistence of the Spike protein, thanks to a strengthened version of CRAPU therapy designed to degrade synthetic mRNA.
At a glance
Talk to the researcher
Leave your details: the request reaches the seminar office, which will get back to you to arrange the meeting.
A collaboration between the Emanuele Association and the BuonSenso Club.
